Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by Canuck21Con Jun 17, 2016 1:51pm
165 Views
Post# 24975119

RE:New Natesto NR

RE:New Natesto NRAfter looking at the lineup for this Canadian Urology Association conference I noticed that Dr. Peter Schlegel from NYC will also be delivering a TRT related talk later on in the afternoon of June 27.  His talk will be entitled "State of the Art Lecture, Testosterone Therapy:  Where are we in 2016?"  He will also be the co-moderator for all the ED/Andrology/Infertility lectures including that of Dr. Rogol.  Dr. Schlegel is a "Top Doctor" rated urologist in the U.S. and is internationally recognized.  He did give a lecture last month in New Orleans which put him squarely on our side in the bogus increased cardio risk debate.  His lecture mentioned the following:regarding the highly publicised previous articles regarding cardiovascular risks: "However, these predominantly observational studies are countered by a series of articles that suggest testosterone treatment of men with hypogonadism 1) improves a variety of aspects of metabolic syndrome including glucose control, 2) assists with weight loss, and 3) is associated with greater longevity."


Bullboard Posts